PRNewsWire - Health - Latest News Search Engine - Global and Local Breaking News

PRNewsWire - Health

Microtech annonce les premières implantations de microcapteurs auriculaires aux États-Unis dans le cadre de son étude FIH

TEL AVIV, Israël, 9 juin 2025 /PRNewswire/ -- Microtech, filiale à 100 % de Medinol, est heureuse d'annoncer les premières implantations aux États-Uni...

Microtech annonce les premières implantations de microcapteurs auriculaires aux États-Unis dans le cadre de son étude FIH

耶穌基督後期聖徒教會加強全球努力，將最初的捐贈預算翻倍，幫助改善全球超過 2,100 萬名婦女和兒童的生活

鹽湖城2025年6月9日 /美通社/ -- 耶穌基督後期聖徒教會 (The Church of Jesus Christ of Latter-day Saints) 一直肩負著照顧有需要的人的責任，為了改善婦女與兒童的福祉，教會正在加強其全球倡議。 2025 年 6 月 5 日（星期四）在猶他州鹽湖...

耶穌基督後期聖徒教會加強全球努力，將最初的捐贈預算翻倍，幫助改善全球超過 2,100 萬名婦女和兒童的生活

Hansa Biopharma to Host Science Deep Dive Virtual Investor Event on Guillain-Barré Syndrome on June 16, 2025

LUND, Sweden, June 9, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced that it will host a virtual investor e...

Hansa Biopharma to Host Science Deep Dive Virtual Investor Event on Guillain-Barré Syndrome on June 16, 2025

Everest Medicines Presents Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of Novel BTK Inhibitor EVER001 at the 62nd Congress ...

EVER001 is a covalent reversible BTK inhibitor with potentially best-in-class characteristics for the treatment of primary membranous nephropathy (pMN...

Everest Medicines Presents Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of Novel BTK Inhibitor EVER001 at the 62nd Congress of the European Renal Association